Cargando…

Contribution of Viral Mimics of Cellular Genes to KSHV Infection and Disease

Kaposi’s sarcoma-associated herpesvirus (KSHV, also named Human herpesvirus 8 HHV-8) is the cause of Kaposi sarcoma (KS), the most common malignancy in HIV-infected individuals worldwide, primary effusion lymphoma (PEL) and multicentric Castleman disease (MCD). KSHV is a double-stranded DNA virus th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakakibara, Shuhei, Tosato, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189034/ https://www.ncbi.nlm.nih.gov/pubmed/25243371 http://dx.doi.org/10.3390/v6093472

Ejemplares similares

Cellular Receptors Involved in KSHV Infection
por: van der Meulen, Emma, et al.
Publicado: (2021)

KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease
por: Polizzotto, Mark N, et al.
Publicado: (2010)

The Role of Bacteria in KSHV Infection and KSHV-Induced Cancers
por: Markazi, Ashley, et al.
Publicado: (2021)

Evidence for altered host genetic factors in KSHV infection and KSHV‐related disease development
por: Blumenthal, Melissa J., et al.
Publicado: (2020)

Cellular gene regulation by K13/VFLIP of Kaposi's sarcoma-associated herpesvirus
por: Sakakibara, S, et al.
Publicado: (2009)

Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection
por: Li, Tingting, et al.
Publicado: (2021)

KSHV LANA—The Master Regulator of KSHV Latency
por: Uppal, Timsy, et al.
Publicado: (2014)

Metabolic reprogramming by KSHV in cellular transformation
por: Zhu, Ying, et al.
Publicado: (2014)

KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
por: Coen, Natacha, et al.
Publicado: (2014)

Identification of Cellular Genes Targeted by KSHV-Encoded MicroRNAs
por: Samols, Mark A, et al.
Publicado: (2007)

Chromatinization of the KSHV Genome During the KSHV Life Cycle
por: Uppal, Timsy, et al.
Publicado: (2015)

KSHV lytic proteins K-RTA and K8 bind to cellular and viral chromatin to modulate gene expression
por: Kaul, Rajeev, et al.
Publicado: (2019)

Polyamine biosynthesis and eIF5A hypusination are modulated by the DNA tumor virus KSHV and promote KSHV viral infection
por: Fiches, Guillaume N., et al.
Publicado: (2022)

Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease
por: Martin de Frémont, Gregoire, et al.
Publicado: (2022)

KSHV Rta Promoter Specification and Viral Reactivation
por: Guito, Jonathan, et al.
Publicado: (2012)

Viral Infection and Autophagy Dysregulation: The Case of HHV-6, EBV and KSHV
por: Romeo, Maria Anele, et al.
Publicado: (2020)

Role of Pattern Recognition Receptors in KSHV Infection
por: Uppal, Timsy, et al.
Publicado: (2018)

EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis
por: Cirone, Mara
Publicado: (2018)

Contribution of the KSHV and EBV lytic cycles to tumourigenesis
por: Manners, Oliver, et al.
Publicado: (2018)

SUMO and KSHV Replication
por: Chang, Pei-Ching, et al.
Publicado: (2014)

The cellular and KSHV A-to-I RNA editome in primary effusion lymphoma and its role in the viral lifecycle
por: Rajendren, Suba, et al.
Publicado: (2023)

Profiling viral and host microRNA expression in cells infected with KSHV and EBV
por: Whitby, D, et al.
Publicado: (2009)

The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?
por: Jacobs, Sarah R., et al.
Publicado: (2011)

Emmprin and KSHV: New partners in viral cancer pathogenesis
por: Dai, Lu, et al.
Publicado: (2013)

Cytokine-Targeted Therapeutics for KSHV-Associated Disease
por: Alomari, Nedaa, et al.
Publicado: (2020)

KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts
por: Qin, Zhiqiang, et al.
Publicado: (2012)

The interplay between EBV and KSHV viral products and NF-κB pathway in oncogenesis
por: Charostad, J., et al.
Publicado: (2020)

Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
por: Velasco, P, et al.
Publicado: (2009)

Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV
por: Gam ze Letova, Chen, et al.
Publicado: (2021)

Sphingosine Kinase-2 Maintains Viral Latency and Survival for KSHV-Infected Endothelial Cells
por: Dai, Lu, et al.
Publicado: (2014)

A Viral Genome Landscape of RNA Polyadenylation from KSHV Latent to Lytic Infection
por: Majerciak, Vladimir, et al.
Publicado: (2013)

KSHV seroprevalence, and blood and saliva viral loads in the HIV-infected population of south Texas
por: Guadalupe, M, et al.
Publicado: (2009)

KSHV Topologically Associating Domains in Latent and Reactivated Viral Chromatin
por: Campbell, Mel, et al.
Publicado: (2022)

KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development
por: Pyakurel, Pawan, et al.
Publicado: (2007)

KSHV and the Role of Notch Receptor Dysregulation in Disease Progression
por: DeCotiis, Jennifer L., et al.
Publicado: (2017)

Long Non-Coding RNA and Epigenetic Gene Regulation of KSHV
por: Campbell, Mel, et al.
Publicado: (2014)

The RNA quality control pathway nonsense-mediated mRNA decay targets cellular and viral RNAs to restrict KSHV
por: Zhao, Yang, et al.
Publicado: (2020)

Heterogeneity and Breadth of Host Antibody Response to KSHV Infection Demonstrated by Systematic Analysis of the KSHV Proteome
por: Labo, Nazzarena, et al.
Publicado: (2014)

Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
por: Uldrick, Thomas, et al.
Publicado: (2010)

Molecular Biology of KSHV Lytic Reactivation
por: Purushothaman, Pravinkumar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m6fdsdlv4bt6kdfku9b1kjtvjc